Drug slows Alzheimer's, but can it make a real difference?
Experimental drug lecanemab slows worsening of brain disease, but benefits unclear
Stay updated with breaking news from Ron Petersen. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Experimental drug lecanemab slows worsening of brain disease, but benefits unclear
Lecanemab, an experimental Alzheimer's drug, modestly slowed the brain disease's inevitable worsening, rese...
An experimental Alzheimer's drug co-developed by Cambridge-based Biogen slowed the brain disease's inevitable worsening, researchers reported.
The drug delayed patients’ worsening by about five months over the course of the study, Japanese drugmaker Eisai’s Dr. Michael Irizarry said.
The trial is important because it shows a drug that attacks a sticky protein called amyloid -- considered one of several culprits behind Alzheimer's -- can delay disease progression.